Correlation Between Stoke Therapeutics and Intellia Therapeutics
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Intellia Therapeutics, you can compare the effects of market volatilities on Stoke Therapeutics and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Intellia Therapeutics.
Diversification Opportunities for Stoke Therapeutics and Intellia Therapeutics
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Stoke and Intellia is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Intellia Therapeutics go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Intellia Therapeutics
Given the investment horizon of 90 days Stoke Therapeutics is expected to generate 1.54 times more return on investment than Intellia Therapeutics. However, Stoke Therapeutics is 1.54 times more volatile than Intellia Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Intellia Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 793.00 in Stoke Therapeutics on November 28, 2024 and sell it today you would earn a total of 28.00 from holding Stoke Therapeutics or generate 3.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Intellia Therapeutics
Performance |
| Timeline |
| Stoke Therapeutics |
| Intellia Therapeutics |
Stoke Therapeutics and Intellia Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Intellia Therapeutics
The main advantage of trading using opposite Stoke Therapeutics and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |